102 related articles for article (PubMed ID: 21324343)
1. Cytofluorimetric evaluation of N-glycolylated GM3 ganglioside expression on murine leukocytes.
Miranda A; de León J; Roque-Navarro L; Fernández LE
Immunol Lett; 2011 Jun; 137(1-2):38-45. PubMed ID: 21324343
[TBL] [Abstract][Full Text] [Related]
2. Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+CD25- effector and naturally occurring CD4+CD25+ regulatory T cells function.
de León J; Fernández A; Clavell M; Labrada M; Bebelagua Y; Mesa C; Fernández LE
Int Immunol; 2008 Apr; 20(4):591-600. PubMed ID: 18310617
[TBL] [Abstract][Full Text] [Related]
3. Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy.
Labrada M; Clavell M; Bebelagua Y; León Jd; Alonso DF; Gabri MR; Veloso RC; Vérez V; Fernández LE
Expert Opin Biol Ther; 2010 Feb; 10(2):153-62. PubMed ID: 20088712
[TBL] [Abstract][Full Text] [Related]
4. Role of tumour-associated N-glycolylated variant of GM3 ganglioside in cancer progression: effect over CD4 expression on T cells.
de Leòn J; Fernández A; Mesa C; Clavel M; Fernández LE
Cancer Immunol Immunother; 2006 Apr; 55(4):443-50. PubMed ID: 16208470
[TBL] [Abstract][Full Text] [Related]
5. A cytotoxic humanized anti-ganglioside antibody produced in a murine cell line defective of N-glycolylated-glycoconjugates.
Fernández-Marrero Y; Roque-Navarro L; Hernández T; Dorvignit D; Molina-Pérez M; González A; Sosa K; López-Requena A; Pérez R; de Acosta CM
Immunobiology; 2011 Dec; 216(12):1239-47. PubMed ID: 21802167
[TBL] [Abstract][Full Text] [Related]
6. Anti-ganglioside antibody-induced tumor cell death by loss of membrane integrity.
Roque-Navarro L; Chakrabandhu K; de León J; Rodríguez S; Toledo C; Carr A; de Acosta CM; Hueber AO; Pérez R
Mol Cancer Ther; 2008 Jul; 7(7):2033-41. PubMed ID: 18645013
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
8. Ganglioside control over IL-4 priming and cytokine production in activated T cells.
Chen XP; Ding X; Daynes RA
Cytokine; 2000 Jul; 12(7):972-85. PubMed ID: 10880242
[TBL] [Abstract][Full Text] [Related]
9. The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction.
Gentilini MV; Pérez ME; Fernández PM; Fainboim L; Arana E
Cancer Immunol Immunother; 2016 May; 65(5):551-62. PubMed ID: 26969612
[TBL] [Abstract][Full Text] [Related]
10. Cancer vaccines: an update with special focus on ganglioside antigens.
Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
[TBL] [Abstract][Full Text] [Related]
11. Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells.
Mascarell L; Lombardi V; Zimmer A; Louise A; Tourdot S; Van Overtvelt L; Moingeon P
Clin Exp Allergy; 2009 Dec; 39(12):1910-9. PubMed ID: 19694757
[TBL] [Abstract][Full Text] [Related]
12. Differential partitioning and trafficking of GM gangliosides and cholesterol-rich lipid rafts in thymic and splenic CD4 T cells.
Brumeanu TD; Preda-Pais A; Stoica C; Bona C; Casares S
Mol Immunol; 2007 Jan; 44(4):530-40. PubMed ID: 16597465
[TBL] [Abstract][Full Text] [Related]
13. Location of major histocompatibility complex class II molecules in rafts on dendritic cells enhances the efficiency of T-cell activation and proliferation.
Eren E; Yates J; Cwynarski K; Preston S; Dong R; Germain C; Lechler R; Huby R; Ritter M; Lombardi G
Scand J Immunol; 2006 Jan; 63(1):7-16. PubMed ID: 16398696
[TBL] [Abstract][Full Text] [Related]
14. Contrasting cytoskeletal regulation of MHC class II peptide presentation by human B cells or dendritic cells.
Delaguillaumie A; Marin-Esteban V; Setterblad N; Leh LJ; Assier E; Gelin C; Charron D; Galy A; Mooney N
Eur J Immunol; 2008 Apr; 38(4):1096-105. PubMed ID: 18393378
[TBL] [Abstract][Full Text] [Related]
15. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
[TBL] [Abstract][Full Text] [Related]
16. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
17. CAR T cells targeting the ganglioside NGcGM3 control ovarian tumors in the absence of toxicity against healthy tissues.
Cribioli E; Giordano Attianese GMP; Coukos G; Irving M
Front Immunol; 2022; 13():951143. PubMed ID: 35990626
[TBL] [Abstract][Full Text] [Related]
18. Distribution of Ly-6C on lymphocyte subsets: I. Influence of allotype on T lymphocyte expression.
Schlueter AJ; Malek TR; Hostetler CN; Smith PA; deVries P; Waldschmidt TJ
J Immunol; 1997 May; 158(9):4211-22. PubMed ID: 9126982
[TBL] [Abstract][Full Text] [Related]
19. Switching on cytotoxicity by a single mutation at the heavy chain variable region of an anti-ganglioside antibody.
Fernández-Marrero Y; Hernández T; Roque-Navarro L; Talavera A; Moreno E; Griñán T; Vázquez AM; de Acosta CM; Pérez R; López-Requena A
Mol Immunol; 2011 Apr; 48(8):1059-67. PubMed ID: 21306777
[TBL] [Abstract][Full Text] [Related]
20. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]